ClinicalTrials.Veeva

Menu

Connect-Home: Alzheimer's Disease and Related Dementias (CH-ADRD)

University of North Carolina (UNC) logo

University of North Carolina (UNC)

Status

Enrolling

Conditions

Alzheimer Disease
Dementia

Treatments

Behavioral: Connect-Home ADRD

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06840587
24-2766
2R01NR017636-05A1 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nursing Facility (SNF) patients with Alzheimer's disease and dementias and their caregivers during transitions from SNFs to home, assisted, living, and long-term care. The primary hypothesis is that the intervention will reduce caregiver strain (Aim 1) and patient neuropsychiatric symptoms (Aim 2).

Full description

Connect-Home ADRD is a Donabedian-guided intervention that introduces new structure and processes to support Skilled Nursing Facility (SNF) staff delivery of transitional care for transitions to home, assisted living, or long-term care, and post-discharge transitional care by the Dementia Caregiving Specialist (DCS).

The research objective is to test the efficacy of Connect-Home ADRD, a transitional care intervention, targeting Skilled Nursing Facility (SNF) patients with Alzheimer's disease and related dementias (ADRD) and their primary caregivers who discharge home and other settings of care. The study will be set in 12 North Carolina SNFs and in the patient's discharge destination (during intervention periods only). Using a cluster-randomized trial design, twelve SNFs will be randomly allocated to an intervention group (N=6 SNFs) and to a control group (N=6 SNFs) by a study statistician masked to SNF identity. 360 dyads of SNF patients with ADRD and caregivers will be enrolled in 12 SNFs.

Enrollment

360 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients:

  • Ability to speak English
  • Goal of discharge to home, assisted living, or long-term care
  • Diagnosis of dementia
  • Having a caregiver willing to participate

Caregivers:

  • Ability to speak English
  • Legally authorized representative (LAR) who also provides support for the person with ADRD

Inclusion criteria for SNFs:

  • Location within 120 miles of UNC-Chapel Hill
  • Admission of at least 75 SNF patients per year

Exclusion criteria

Patients:

  • Planned hospital readmission for procedures or treatments within 30 days post enrollment.

Caregivers:

  • LAR is a court-appointed guardian.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

360 participants in 2 patient groups

Connect-Home ADRD Intervention
Experimental group
Description:
The Connect-Home ADRD Intervention will include: 1. Support for SNF staff delivery of transitional care processes including a ADRD transition plan and booklet, caregiver training and engagement, and handoff of care to community providers and Dementia Caregiving Specialist. 2. Support for patients and caregivers provided by the Dementia Caregiving Specialist in three follow-up supportive telephone calls within 30 days of SNF discharge.
Treatment:
Behavioral: Connect-Home ADRD
Standard Care - Control Group
No Intervention group
Description:
Patient and caregiver dyad randomized to the control arm will receive usual SNF and post-discharge care.

Trial contacts and locations

1

Loading...

Central trial contact

Kathryn Wessell, MPH; Molly Lynch, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems